Direct communication with healthcare professionals.

Recent study data suggest that fluoroquinolones continue to be prescribed outside of the recommended uses.

Systemic and inhaled fluoroquinolones are associated with very rare, serious, disabling, long-lasting and potentially irreversible adverse reactions. These products should be prescribed only for approved indications and after careful assessment of the benefits and risks in the individual patient.